English

HELIX BIOMEDIX INC

EDGAR

Quarterly report (10-Q) · filed 2012-11-08

77 filing records in this dataset, filed from 1996-05-16 to 2012-11-08. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

469 thousand USD

2012 Q3 · USD

Exact inputs and evidence

Revenue: 469071 USD Source

Operating margin

-159.5%

2012 Q3 · %

Exact inputs and evidence

Operating Income: -748173 USD Source
Revenue: 469071 USD Source

Operating cash flow

-512 thousand USD

2012 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -1434680 USD Source
Operating Cash Flow: -922837 USD Source

Cash and cash equivalents: 217 thousand USD 2012-09-30 Source
Exact value

216534 USD
Long-term debt including current maturities: Not available
Shares outstanding: 49.7 million shares 2012-09-30 Source
Exact value

49720255 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

49720255 shares · 2011-09-30· Source
49720255 shares · 2012-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.07 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Revenue: 1891338 USD · 2011-01-01 – 2011-12-31 Source
Revenue: 1445438 USD · 2011-01-01 – 2011-09-30 Source
Revenue: 680422 USD · 2012-01-01 – 2012-03-31 Source
Revenue: 470522 USD · 2012-04-01 – 2012-06-30 Source
Revenue: 469071 USD · 2012-07-01 – 2012-09-30 Source

Net income

-2.58 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Net income: -2488576 USD · 2011-01-01 – 2011-12-31 Source
Net income: -1940226 USD · 2011-01-01 – 2011-09-30 Source
Net income: -581838 USD · 2012-01-01 – 2012-03-31 Source
Net income: -668299 USD · 2012-04-01 – 2012-06-30 Source
Net income: -785184 USD · 2012-07-01 – 2012-09-30 Source

Operating cash flow

-1.82 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: -2296040 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: -1911723 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: -525411 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -922837 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -525411 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -1434680 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -922837 USD · 2012-01-01 – 2012-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-11-08.

Financial data available through: 2011-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2011-12-31
Operating income: 11 of 11 periods available· newest 2011-12-31
Net income: 11 of 11 periods available· newest 2011-12-31
Operating cash flow: 11 of 11 periods available· newest 2011-12-31
Capital expenditure: 11 of 11 periods available· newest 2011-12-31
Total assets: 11 of 11 periods available· newest 2011-12-31
Total liabilities: 7 of 11 periods available· newest 2011-12-31
Current assets: 11 of 11 periods available· newest 2011-12-31
Current liabilities: 11 of 11 periods available· newest 2011-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2011-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+122.1%

Prior period

USD 851,683

2010-01-01 – 2010-12-31
Current period

USD 1.89 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

1891338 − 851683 = 1039655 USD

851683 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
1891338 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HELIX BIOMEDIX INC · 2011-12-31 HELIX BIOMEDIX INC (edgar:831749) Year-over-year change in Revenue: 1039655 USD Concept: fundies:Revenue Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1891338 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#13646 Filing: 000143774912002826 Input fundies:Revenue: 851683 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#13757 Filing: 000143774912002826
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 5.22 million

Prior period

−USD 7.71 million

2010-01-01 – 2010-12-31
Current period

−USD 2.49 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-2488576 − -7710802 = 5222226 USD

-7710802 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-2488576 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HELIX BIOMEDIX INC · 2011-12-31 HELIX BIOMEDIX INC (edgar:831749) Year-over-year change in Net income: 5222226 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2488576 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912011259/hxbm-20120930.xml#68124 Filing: 000143774912011259 Input fundies:NetIncome: -7710802 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#24337 Filing: 000143774912002826
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 500,829

Prior period

−USD 2.8 million

2010-01-01 – 2010-12-31
Current period

−USD 2.3 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-2296040 − -2796869 = 500829 USD

-2796869 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-2296040 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HELIX BIOMEDIX INC · 2011-12-31 HELIX BIOMEDIX INC (edgar:831749) Year-over-year change in Operating cash flow: 500829 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2296040 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#41508 Filing: 000143774912002826 Input fundies:OperatingCashFlow: -2796869 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#41688 Filing: 000143774912002826
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-49.7%

Prior period

USD 5,305

2010-01-01 – 2010-12-31
Current period

USD 2,669

2011-01-01 – 2011-12-31

Exact inputs and evidence

2669 − 5305 = -2636 USD

5305 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
2669 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HELIX BIOMEDIX INC · 2011-12-31 HELIX BIOMEDIX INC (edgar:831749) Year-over-year change in Capital expenditure: -2636 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2669 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#42597 Filing: 000143774912002826 Input fundies:CapitalExpenditure: 5305 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#42773 Filing: 000143774912002826
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

Revenue USD 1.89 million 100% of revenue
Cost of revenue USD 733,307 39% of revenue
Operating expenses USD 3.56 million 188% of revenue
Operating income −USD 2.4 million −127% of revenue
Tax, interest and other Derived USD 84,253 4.5% of revenue
Net income −USD 2.49 million −132% of revenue

Cash

Operating cash flow −USD 2.3 million −121% of revenue
Capital expenditure USD 2,669 0.1% of revenue
Free cash flow Derived −USD 2.3 million −122% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Operating loss: operating costs were 3,622% of revenue.
2003 Operating loss: operating costs were 3,731% of revenue.
2004 Operating loss: operating costs were 3,450% of revenue.
2005 Operating loss: operating costs were 3,166% of revenue.
2006 Operating loss: operating costs were 5,602% of revenue.
2007 Operating loss: operating costs were 858% of revenue.
2008 Operating loss: operating costs were 730% of revenue.
2009 Operating loss: operating costs were 922% of revenue.
2010 Operating loss: operating costs were 447% of revenue.
2011 Operating loss: operating costs were 227% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	70000	2535412 Derived	-2465412	696492 Derived	-3161904	-1703411 Derived	Source 2002-01-01 – 2002-12-31: 70000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -2465412 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -3161904 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -1672492 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 30919 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	88465	3300425 Derived	-3211960	-16457 Derived	-3195503	-2389389 Derived	Source 2003-01-01 – 2003-12-31: 88465 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -3211960 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -3195503 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -2078947 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 310442 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	93661	3231498 Derived	-3137837	-28563 Derived	-3109274	-2520073 Derived	Source 2004-01-01 – 2004-12-31: 93661 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -3137837 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -3109274 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -2515594 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 4479 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	108408	3431733 Derived	-3323325	-46086 Derived	-3277239	-2876118 Derived	Source 2005-01-01 – 2005-12-31: 108408 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -3323325 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -3277239 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -2822974 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 53144 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	70940	3973874 Derived	-3902934	-74608 Derived	-3828326	-3155614 Derived	Source 2006-01-01 – 2006-12-31: 70940 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -3902934 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -3828326 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -3025361 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 130253 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	463941	3982520 Derived	-3518579	-84575 Derived	-3434004	-3238969 Derived	Source 2007-01-01 – 2007-12-31: 463941 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -3518579 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -3434004 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -3211842 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 27127 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	562877	4107055 Derived	-3544178	971334 Derived	-4515512	-3154186 Derived	Source 2008-01-01 – 2008-12-31: 562877 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -3544178 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -4515512 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -3141666 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 12520 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	391268	3609176 Derived	-3217908	557127 Derived	-3775035	-3088605 Derived	Source 2009-01-01 – 2009-12-31: 391268 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -3217908 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -3775035 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -3071568 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 17037 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	851683	3807839 Derived	-2956156	4754646 Derived	-7710802	-2802174 Derived	Source 2010-01-01 – 2010-12-31: 851683 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -2956156 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -7710802 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -2796869 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 5305 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	1891338	4295661 Derived	-2404323	84253 Derived	-2488576	-2298709 Derived	Source 2011-01-01 – 2011-12-31: 1891338 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -2404323 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -2488576 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -2296040 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 2669 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.9M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	70000	Revenue: 70000 Open source
20032003-12-31	Revenue	88465	Revenue: 88465 Open source
20042004-12-31	Revenue	93661	Revenue: 93661 Open source
20052005-12-31	Revenue	108408	Revenue: 108408 Open source
20062006-12-31	Revenue	70940	Revenue: 70940 Open source
20072007-12-31	Revenue	463941	Revenue: 463941 Open source
20082008-12-31	Revenue	562877	Revenue: 562877 Open source
20092009-12-31	Revenue	391268	Revenue: 391268 Open source
20102010-12-31	Revenue	851683	Revenue: 851683 Open source
20112011-12-31	Revenue	1891338	Revenue: 1891338 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

122.1% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 70000 Open source Revenue: 0 Open source
20032003-12-31	Year over year	26.4%	Revenue: 88465 Open source Revenue: 70000 Open source
20042004-12-31	Year over year	5.9%	Revenue: 93661 Open source Revenue: 88465 Open source
20052005-12-31	Year over year	15.7%	Revenue: 108408 Open source Revenue: 93661 Open source
20062006-12-31	Year over year	-34.6%	Revenue: 70940 Open source Revenue: 108408 Open source
20072007-12-31	Year over year	554%	Revenue: 463941 Open source Revenue: 70940 Open source
20082008-12-31	Year over year	21.3%	Revenue: 562877 Open source Revenue: 463941 Open source
20092009-12-31	Year over year	-30.5%	Revenue: 391268 Open source Revenue: 562877 Open source
20102010-12-31	Year over year	117.7%	Revenue: 851683 Open source Revenue: 391268 Open source
20112011-12-31	Year over year	122.1%	Revenue: 1891338 Open source Revenue: 851683 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -127.1% 2011

Net margin -131.6% 2011

Free cash flow margin -121.5% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Operating margin	-3,522%	Operating Income: -2465412 Open source Revenue: 70000 Open source
20032003-12-31	Operating margin	-3,630.8%	Operating Income: -3211960 Open source Revenue: 88465 Open source
20042004-12-31	Operating margin	-3,350.2%	Operating Income: -3137837 Open source Revenue: 93661 Open source
20052005-12-31	Operating margin	-3,065.6%	Operating Income: -3323325 Open source Revenue: 108408 Open source
20062006-12-31	Operating margin	-5,501.7%	Operating Income: -3902934 Open source Revenue: 70940 Open source
20072007-12-31	Operating margin	-758.4%	Operating Income: -3518579 Open source Revenue: 463941 Open source
20082008-12-31	Operating margin	-629.7%	Operating Income: -3544178 Open source Revenue: 562877 Open source
20092009-12-31	Operating margin	-822.4%	Operating Income: -3217908 Open source Revenue: 391268 Open source
20102010-12-31	Operating margin	-347.1%	Operating Income: -2956156 Open source Revenue: 851683 Open source
20112011-12-31	Operating margin	-127.1%	Operating Income: -2404323 Open source Revenue: 1891338 Open source
20022002-12-31	Net margin	-4,517%	Net Income: -3161904 Open source Revenue: 70000 Open source
20032003-12-31	Net margin	-3,612.2%	Net Income: -3195503 Open source Revenue: 88465 Open source
20042004-12-31	Net margin	-3,319.7%	Net Income: -3109274 Open source Revenue: 93661 Open source
20052005-12-31	Net margin	-3,023.1%	Net Income: -3277239 Open source Revenue: 108408 Open source
20062006-12-31	Net margin	-5,396.6%	Net Income: -3828326 Open source Revenue: 70940 Open source
20072007-12-31	Net margin	-740.2%	Net Income: -3434004 Open source Revenue: 463941 Open source
20082008-12-31	Net margin	-802.2%	Net Income: -4515512 Open source Revenue: 562877 Open source
20092009-12-31	Net margin	-964.8%	Net Income: -3775035 Open source Revenue: 391268 Open source
20102010-12-31	Net margin	-905.4%	Net Income: -7710802 Open source Revenue: 851683 Open source
20112011-12-31	Net margin	-131.6%	Net Income: -2488576 Open source Revenue: 1891338 Open source
20022002-12-31	Free cash flow margin	-2,433.4%	Revenue: 70000 Open source Operating Cash Flow: -1672492 Open source Capital Expenditure: 30919 Open source
20032003-12-31	Free cash flow margin	-2,700.9%	Revenue: 88465 Open source Operating Cash Flow: -2078947 Open source Capital Expenditure: 310442 Open source
20042004-12-31	Free cash flow margin	-2,690.6%	Revenue: 93661 Open source Operating Cash Flow: -2515594 Open source Capital Expenditure: 4479 Open source
20052005-12-31	Free cash flow margin	-2,653%	Revenue: 108408 Open source Operating Cash Flow: -2822974 Open source Capital Expenditure: 53144 Open source
20062006-12-31	Free cash flow margin	-4,448.3%	Revenue: 70940 Open source Operating Cash Flow: -3025361 Open source Capital Expenditure: 130253 Open source
20072007-12-31	Free cash flow margin	-698.1%	Revenue: 463941 Open source Operating Cash Flow: -3211842 Open source Capital Expenditure: 27127 Open source
20082008-12-31	Free cash flow margin	-560.4%	Revenue: 562877 Open source Operating Cash Flow: -3141666 Open source Capital Expenditure: 12520 Open source
20092009-12-31	Free cash flow margin	-789.4%	Revenue: 391268 Open source Operating Cash Flow: -3071568 Open source Capital Expenditure: 17037 Open source
20102010-12-31	Free cash flow margin	-329%	Revenue: 851683 Open source Operating Cash Flow: -2796869 Open source Capital Expenditure: 5305 Open source
20112011-12-31	Free cash flow margin	-121.5%	Revenue: 1891338 Open source Operating Cash Flow: -2296040 Open source Capital Expenditure: 2669 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.3M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	-1672492	Operating Cash Flow: -1672492 Open source
20032003-12-31	Operating cash flow	-2078947	Operating Cash Flow: -2078947 Open source
20042004-12-31	Operating cash flow	-2515594	Operating Cash Flow: -2515594 Open source
20052005-12-31	Operating cash flow	-2822974	Operating Cash Flow: -2822974 Open source
20062006-12-31	Operating cash flow	-3025361	Operating Cash Flow: -3025361 Open source
20072007-12-31	Operating cash flow	-3211842	Operating Cash Flow: -3211842 Open source
20082008-12-31	Operating cash flow	-3141666	Operating Cash Flow: -3141666 Open source
20092009-12-31	Operating cash flow	-3071568	Operating Cash Flow: -3071568 Open source
20102010-12-31	Operating cash flow	-2796869	Operating Cash Flow: -2796869 Open source
20112011-12-31	Operating cash flow	-2296040	Operating Cash Flow: -2296040 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2.3M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	-1703411	Operating Cash Flow: -1672492 Open source Capital Expenditure: 30919 Open source
20032003-12-31	Free cash flow	-2389389	Operating Cash Flow: -2078947 Open source Capital Expenditure: 310442 Open source
20042004-12-31	Free cash flow	-2520073	Operating Cash Flow: -2515594 Open source Capital Expenditure: 4479 Open source
20052005-12-31	Free cash flow	-2876118	Operating Cash Flow: -2822974 Open source Capital Expenditure: 53144 Open source
20062006-12-31	Free cash flow	-3155614	Operating Cash Flow: -3025361 Open source Capital Expenditure: 130253 Open source
20072007-12-31	Free cash flow	-3238969	Operating Cash Flow: -3211842 Open source Capital Expenditure: 27127 Open source
20082008-12-31	Free cash flow	-3154186	Operating Cash Flow: -3141666 Open source Capital Expenditure: 12520 Open source
20092009-12-31	Free cash flow	-3088605	Operating Cash Flow: -3071568 Open source Capital Expenditure: 17037 Open source
20102010-12-31	Free cash flow	-2802174	Operating Cash Flow: -2796869 Open source Capital Expenditure: 5305 Open source
20112011-12-31	Free cash flow	-2298709	Operating Cash Flow: -2296040 Open source Capital Expenditure: 2669 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

14.8% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Liabilities / assets	82.9%	Total Liabilities: 1807856 Open source Total Assets: 2180025 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 3139948 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 2867080 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 3741940 Open source
20062006-12-31	Liabilities / assets	8.6%	Total Liabilities: 262467 Open source Total Assets: 3060544 Open source
20072007-12-31	Liabilities / assets	17.4%	Total Liabilities: 351358 Open source Total Assets: 2022071 Open source
20082008-12-31	Liabilities / assets	163.4%	Total Liabilities: 4418229 Open source Total Assets: 2703707 Open source
20092009-12-31	Liabilities / assets	356.8%	Total Liabilities: 7181645 Open source Total Assets: 2012920 Open source
20102010-12-31	Liabilities / assets	6.8%	Total Liabilities: 354038 Open source Total Assets: 5228482 Open source
20112011-12-31	Liabilities / assets	14.8%	Total Liabilities: 439303 Open source Total Assets: 2974639 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.23× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Current assets / current liabilities	2.95×	Current Assets: 1099167 Open source Current Liabilities: 372169 Open source
20032003-12-31	Current assets / current liabilities	10.35×	Current Assets: 2128706 Open source Current Liabilities: 205753 Open source
20042004-12-31	Current assets / current liabilities	10.69×	Current Assets: 2009299 Open source Current Liabilities: 188046 Open source
20052005-12-31	Current assets / current liabilities	13.3×	Current Assets: 2983626 Open source Current Liabilities: 224359 Open source
20062006-12-31	Current assets / current liabilities	8.95×	Current Assets: 2350243 Open source Current Liabilities: 262467 Open source
20072007-12-31	Current assets / current liabilities	4.17×	Current Assets: 1454558 Open source Current Liabilities: 349153 Open source
20082008-12-31	Current assets / current liabilities	1.84×	Current Assets: 2221428 Open source Current Liabilities: 1207160 Open source
20092009-12-31	Current assets / current liabilities	11.48×	Current Assets: 1637680 Open source Current Liabilities: 142654 Open source
20102010-12-31	Current assets / current liabilities	14.69×	Current Assets: 4674116 Open source Current Liabilities: 318223 Open source
20112011-12-31	Current assets / current liabilities	6.23×	Current Assets: 2558105 Open source Current Liabilities: 410643 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	−USD 3.16 million Exact value Exact value: -3161904 USD 2002-01-01 – 2002-12-31: -3161904 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2002-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -3161904 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3161904 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-04-001211.txt#11373 The citation records this snapshot. The page link may show a newer release later.	−USD 1.67 million Exact value Exact value: -1672492 USD 2002-01-01 – 2002-12-31: -1672492 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2002-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -1672492 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1672492 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-04-001211.txt#11709 The citation records this snapshot. The page link may show a newer release later.	USD 30,919 Exact value Exact value: 30919 USD 2002-01-01 – 2002-12-31: 30919 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2002-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 30919 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30919 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-04-001211.txt#11787 The citation records this snapshot. The page link may show a newer release later.	−USD 1.7 million Calculation and evidence -1672492 − 30919 USD Exact free cash flow: -1703411 USD 2002-01-01 – 2002-12-31: -1672492 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 30919 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2002-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -1703411 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1672492 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-04-001211.txt#11709 Input fundies:CapitalExpenditure: 30919 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-04-001211.txt#11787 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 3.2 million Exact value Exact value: -3195503 USD 2003-01-01 – 2003-12-31: -3195503 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2003-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -3195503 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3195503 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-05-002132.txt#10177 The citation records this snapshot. The page link may show a newer release later.	−USD 2.08 million Exact value Exact value: -2078947 USD 2003-01-01 – 2003-12-31: -2078947 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2003-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -2078947 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2078947 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-05-002132.txt#10518 The citation records this snapshot. The page link may show a newer release later.	USD 310,442 Exact value Exact value: 310442 USD 2003-01-01 – 2003-12-31: 310442 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2003-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 310442 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 310442 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-05-002132.txt#10611 The citation records this snapshot. The page link may show a newer release later.	−USD 2.39 million Calculation and evidence -2078947 − 310442 USD Exact free cash flow: -2389389 USD 2003-01-01 – 2003-12-31: -2078947 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 310442 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2003-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -2389389 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2078947 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-05-002132.txt#10518 Input fundies:CapitalExpenditure: 310442 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-05-002132.txt#10611 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 3.11 million Exact value Exact value: -3109274 USD 2004-01-01 – 2004-12-31: -3109274 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2004-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -3109274 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3109274 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-06-001484.txt#11049 The citation records this snapshot. The page link may show a newer release later.	−USD 2.52 million Exact value Exact value: -2515594 USD 2004-01-01 – 2004-12-31: -2515594 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2004-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -2515594 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2515594 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-06-001484.txt#11412 The citation records this snapshot. The page link may show a newer release later.	USD 4,479 Exact value Exact value: 4479 USD 2004-01-01 – 2004-12-31: 4479 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2004-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 4479 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4479 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-06-001484.txt#11505 The citation records this snapshot. The page link may show a newer release later.	−USD 2.52 million Calculation and evidence -2515594 − 4479 USD Exact free cash flow: -2520073 USD 2004-01-01 – 2004-12-31: -2515594 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 4479 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2004-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -2520073 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2515594 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-06-001484.txt#11412 Input fundies:CapitalExpenditure: 4479 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0000950124-06-001484.txt#11505 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 3.28 million Exact value Exact value: -3277239 USD 2005-01-01 – 2005-12-31: -3277239 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2005-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -3277239 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3277239 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-08-062792.txt#3288 The citation records this snapshot. The page link may show a newer release later.	−USD 2.82 million Exact value Exact value: -2822974 USD 2005-01-01 – 2005-12-31: -2822974 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2005-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -2822974 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2822974 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-08-062792.txt#3512 The citation records this snapshot. The page link may show a newer release later.	USD 53,144 Exact value Exact value: 53144 USD 2005-01-01 – 2005-12-31: 53144 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2005-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 53144 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 53144 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-08-062792.txt#3596 The citation records this snapshot. The page link may show a newer release later.	−USD 2.88 million Calculation and evidence -2822974 − 53144 USD Exact free cash flow: -2876118 USD 2005-01-01 – 2005-12-31: -2822974 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 53144 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2005-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -2876118 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2822974 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-08-062792.txt#3512 Input fundies:CapitalExpenditure: 53144 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-08-062792.txt#3596 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 3.83 million Exact value Exact value: -3828326 USD 2006-01-01 – 2006-12-31: -3828326 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2006-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -3828326 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3828326 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-09-064369.txt#5318 The citation records this snapshot. The page link may show a newer release later.	−USD 3.03 million Exact value Exact value: -3025361 USD 2006-01-01 – 2006-12-31: -3025361 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2006-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -3025361 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3025361 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-09-064369.txt#5612 The citation records this snapshot. The page link may show a newer release later.	USD 130,253 Exact value Exact value: 130253 USD 2006-01-01 – 2006-12-31: 130253 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2006-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 130253 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 130253 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-09-064369.txt#5710 The citation records this snapshot. The page link may show a newer release later.	−USD 3.16 million Calculation and evidence -3025361 − 130253 USD Exact free cash flow: -3155614 USD 2006-01-01 – 2006-12-31: -3025361 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 130253 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2006-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -3155614 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3025361 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-09-064369.txt#5612 Input fundies:CapitalExpenditure: 130253 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-09-064369.txt#5710 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 3.43 million Exact value Exact value: -3434004 USD 2007-01-01 – 2007-12-31: -3434004 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2007-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -3434004 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3434004 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-10-065700.txt#5220 The citation records this snapshot. The page link may show a newer release later.	−USD 3.21 million Exact value Exact value: -3211842 USD 2007-01-01 – 2007-12-31: -3211842 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2007-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -3211842 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3211842 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-10-065700.txt#5528 The citation records this snapshot. The page link may show a newer release later.	USD 27,127 Exact value Exact value: 27127 USD 2007-01-01 – 2007-12-31: 27127 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2007-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 27127 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27127 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-10-065700.txt#5612 The citation records this snapshot. The page link may show a newer release later.	−USD 3.24 million Calculation and evidence -3211842 − 27127 USD Exact free cash flow: -3238969 USD 2007-01-01 – 2007-12-31: -3211842 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 27127 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2007-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -3238969 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3211842 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-10-065700.txt#5528 Input fundies:CapitalExpenditure: 27127 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001193125-10-065700.txt#5612 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 4.52 million Exact value Exact value: -4515512 USD 2008-01-01 – 2008-12-31: -4515512 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2008-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -4515512 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4515512 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001437749-11-001720.txt#8027 The citation records this snapshot. The page link may show a newer release later.	−USD 3.14 million Exact value Exact value: -3141666 USD 2008-01-01 – 2008-12-31: -3141666 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2008-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -3141666 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3141666 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001437749-11-001720.txt#8421 The citation records this snapshot. The page link may show a newer release later.	USD 12,520 Exact value Exact value: 12520 USD 2008-01-01 – 2008-12-31: 12520 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2008-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 12520 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12520 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001437749-11-001720.txt#8507 The citation records this snapshot. The page link may show a newer release later.	−USD 3.15 million Calculation and evidence -3141666 − 12520 USD Exact free cash flow: -3154186 USD 2008-01-01 – 2008-12-31: -3141666 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 12520 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2008-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -3154186 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3141666 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001437749-11-001720.txt#8421 Input fundies:CapitalExpenditure: 12520 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/0001437749-11-001720.txt#8507 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 3.78 million Exact value Exact value: -3775035 USD 2009-01-01 – 2009-12-31: -3775035 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2009-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -3775035 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3775035 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#24459 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.	−USD 3.07 million Exact value Exact value: -3071568 USD 2009-01-01 – 2009-12-31: -3071568 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2009-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -3071568 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3071568 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#41868 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.	USD 17,037 Exact value Exact value: 17037 USD 2009-01-01 – 2009-12-31: 17037 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2009-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 17037 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17037 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#42949 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.	−USD 3.09 million Calculation and evidence -3071568 − 17037 USD Exact free cash flow: -3088605 USD 2009-01-01 – 2009-12-31: -3071568 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 17037 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2009-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -3088605 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3071568 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#41868 Filing: 000143774912002826 Input fundies:CapitalExpenditure: 17037 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#42949 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 7.71 million Exact value Exact value: -7710802 USD 2010-01-01 – 2010-12-31: -7710802 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2010-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -7710802 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7710802 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#24337 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.	−USD 2.8 million Exact value Exact value: -2796869 USD 2010-01-01 – 2010-12-31: -2796869 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2010-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -2796869 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2796869 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#41688 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.	USD 5,305 Exact value Exact value: 5305 USD 2010-01-01 – 2010-12-31: 5305 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2010-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 5305 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5305 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#42773 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.	−USD 2.8 million Calculation and evidence -2796869 − 5305 USD Exact free cash flow: -2802174 USD 2010-01-01 – 2010-12-31: -2796869 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 5305 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2010-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -2802174 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2796869 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#41688 Filing: 000143774912002826 Input fundies:CapitalExpenditure: 5305 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#42773 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 2.49 million Exact value Exact value: -2488576 USD 2011-01-01 – 2011-12-31: -2488576 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELIX BIOMEDIX INC · 2011-12-31 HELIX BIOMEDIX INC (edgar:831749) Net Income: -2488576 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2488576 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912011259/hxbm-20120930.xml#68124 Filing: 000143774912011259 The citation records this snapshot. The page link may show a newer release later.	−USD 2.3 million Exact value Exact value: -2296040 USD 2011-01-01 – 2011-12-31: -2296040 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELIX BIOMEDIX INC · 2011-12-31 HELIX BIOMEDIX INC (edgar:831749) Operating Cash Flow: -2296040 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2296040 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#41508 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.	USD 2,669 Exact value Exact value: 2669 USD 2011-01-01 – 2011-12-31: 2669 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELIX BIOMEDIX INC · 2011-12-31 HELIX BIOMEDIX INC (edgar:831749) Capital Expenditure: 2669 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2669 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#42597 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.	−USD 2.3 million Calculation and evidence -2296040 − 2669 USD Exact free cash flow: -2298709 USD 2011-01-01 – 2011-12-31: -2296040 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 2669 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELIX BIOMEDIX INC · 2011-12-31 HELIX BIOMEDIX INC (edgar:831749) Free cash flow: -2298709 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T03:33:41Z Snapshot: abd8a7130f626397ecf79141841cc6d6040dad5a05d114d70144df756433f703 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831749?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2296040 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#41508 Filing: 000143774912002826 Input fundies:CapitalExpenditure: 2669 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831749/000143774912002826/hxbm-20111231.xml#42597 Filing: 000143774912002826 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

77 filings · 628 latest values · 628 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000831749, 831749, edgar:831749

Also known as HELIX BIOMEDIX INC

HELIX BIOMEDIX INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2011-01-01 – 2011-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation